Lv31
210 积分 2024-05-30 加入
Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD
6小时前
待确认
Pharmacokinetics and Safety Study of HN0037, a Novel Anti‐Human Herpes Simplex Virus Inhibitor, in Healthy Volunteers
21天前
已完结
Clinical and Molecular Genetics of the Phosphodiesterases (PDEs)
26天前
已完结
Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases
1个月前
已完结
Current and Emerging Prodrug Strategies
2个月前
已完结
Male premating treatment in FEED studies: Length is not everything
2个月前
已完结
IL-27 signalling promotes adipocyte thermogenesis and energy expenditure
2个月前
已完结
Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα)
2个月前
已完结
Lipoprotein(a)-lowering therapies: a promising future
3个月前
已完结
皖公网安备34019202002308
